Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20091
20102
20114
20131
20142
20152
20172
20201
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting3
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Incyte Corporation3
Novartis Pharmaceuticals3
Gilead Sciences2
AstraZeneca1
Faes Farma, S.A.1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Pascoe Pharmazeutische Praeparate GmbH1
Pharmacyclics LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome22
Lymphoma, Follicular5
Psoriasis4
Leukemia3
Pruritus3
Graft vs Host Disease2
Hepatitis C2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Anemia1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.